세계의 정맥내 주입 펌프 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)

The global demand for Intravenous Infusion Pump Market is presumed to reach the market size of nearly USD 18.83 BN by 2030 from USD 8.52 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.

An intravenous infusion pump is a medical device used to deliver fluids, medications, and nutrients directly into a patient's bloodstream through a vein. These devices are typically used in hospitals, clinics, and other healthcare settings to deliver a precise and controlled amount of fluids or medications over a set period of time. Intravenous infusion pumps are designed to accurately control the flow rate of fluids or medications into the patient's bloodstream. They typically consist of a pump mechanism, a reservoir for the fluid or medication, and a delivery system that is connected to the patient's vein through an intravenous catheter. These pumps can be programmed to deliver a specific volume of fluid or medication over a set period of time, allowing for precise dosing and delivery. They are commonly used to administer intravenous antibiotics, chemotherapy drugs, and other medications that require a controlled and precise delivery. Intravenous infusion pumps may also have additional features, such as the ability to detect air bubbles in the tubing or to deliver multiple medications simultaneously. Some models may also be portable or wearable, allowing patients to receive treatment at home or while on the go.

Market Dynamics:

As the global population ages and the incidence of diseases which are chronic in nature, such as cancer, diabetes, and cardiovascular disease, continues to rise, the demand for intravenous infusion pumps is expected to increase. These pumps are commonly used to deliver medications and fluids to patients with chronic conditions, and as the number of people with these conditions increases, so too will the demand for infusion pumps. New and innovative intravenous infusion pumps that are more accurate, reliable, and user-friendly. These pumps often include features such as wireless connectivity, touchscreen interfaces, and automated monitoring and alerts, which make them easier to use and improve patient safety. As healthcare costs continue to rise and hospitals look for ways to reduce readmissions, there is a growing demand for home healthcare services. Intravenous infusion pumps are an important component of many home healthcare treatments, as they allow patients to receive medication and fluids at home without needing to visit a hospital or clinic. The number of surgical procedures being performed globally is on the rise, driving the demand for intravenous infusion pumps. These pumps are commonly used during surgery to deliver anaesthesia and other medications, and as the number of surgical procedures increases, so too will the demand for infusion pumps. In many countries, healthcare systems provide reimbursement for the use of intravenous infusion pumps, which helps to drive demand for these devices. Reimbursement policies vary by country and by type of infusion pump, but in general, favourable policies are expected to assist the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of intravenous infusion pump. The growth and trends of intravenous infusion pump industry provide a holistic approach to this study.

Market Segmentation:

This section of the intravenous infusion pump market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Enteral Infusion Pumps
• Ambulatory Infusion Pumps
• Patient Controlled Analgesia (PCA)
• Implantable Infusion Pumps
• Others

By Disease Indication

• Chemotherapy
• Diabetes
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics/Neonatology
• Hematology
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Intravenous Infusion Pump market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intravenous infusion pump market include Baxter International, B. Braun Melsungen AG, Medtronic, Micrel Medical Devices SA, Boston Scientific Corporation, CareFusion Corporation, Fresenius Kabi, Smiths Medical, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care Inc., Terumo Corporation, Mindray, Moog Inc., IRadimed Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . INTRAVENOUS INFUSION PUMP - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Disease Indication
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Volumetric Infusion Pumps Historic and Forecast Sales by Regions
• 6.5 Insulin Infusion Pumps Historic and Forecast Sales by Regions
• 6.6 Syringe Infusion Pumps Historic and Forecast Sales by Regions
• 6.7 Enteral Infusion Pumps Historic and Forecast Sales by Regions
• 6.8 Ambulatory Infusion Pumps Historic and Forecast Sales by Regions
• 6.9 Patient Controlled Analgesia (PCA) Historic and Forecast Sales by Regions
• 6.10. Implantable Infusion Pumps Historic and Forecast Sales by Regions
• 6.11 Others Historic and Forecast Sales by Regions

7 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY DISEASE INDICATION

• 7.1 Overview by Disease Indication
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Disease Indication
• 7.4 Chemotherapy Historic and Forecast Sales by Regions
• 7.5 Diabetes Historic and Forecast Sales by Regions
• 7.6 Gastroenterology Historic and Forecast Sales by Regions
• 7.7 Analgesia/Pain Management Historic and Forecast Sales by Regions
• 7.8 Pediatrics/Neonatology Historic and Forecast Sales by Regions
• 7.9 Hematology Historic and Forecast Sales by Regions
• 7.10. Others Historic and Forecast Sales by Regions

8 . GLOBAL INTRAVENOUS INFUSION PUMP MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE INTRAVENOUS INFUSION PUMP COMPANIES

• 9.1. Intravenous Infusion Pump Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF INTRAVENOUS INFUSION PUMP INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Baxter International
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. B. Braun Melsungen AG
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Medtronic
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Micrel Medical Devices SA
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Boston Scientific Corporation
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. CareFusion Corporation
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Fresenius Kabi
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Smiths Medical
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. F. Hoffmann-La Roche Ltd.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Tandem Diabetes Care Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. Terumo Corporation
  • 10.13.1. Company Overview
  • 10.13.2. Company Revenue
  • 10.13.3. Products
  • 10.13.4. Recent Developments
• 10.14. Mindray
  • 10.14.1. Company Overview
  • 10.14.2. Company Revenue
  • 10.14.3. Products
  • 10.14.4. Recent Developments
• 10.15. Moog Inc.
  • 10.15.1. Company Overview
  • 10.15.2. Company Revenue
  • 10.15.3. Products
  • 10.15.4. Recent Developments
• 10.16. IRadimed Corporation
  • 10.16.1. Company Overview
  • 10.16.2. Company Revenue
  • 10.16.3. Products
  • 10.16.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies